ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer

ClinicalTrials.gov ID: NCT00274937

Public ClinicalTrials.gov record NCT00274937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy: A Groupwide Phase III Study

Study identification

NCT ID
NCT00274937
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Children's Oncology Group
Network
Enrollment
111 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
Up to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 19, 2006
Primary completion
Dec 30, 2014
Completion
Sep 29, 2022
Last update posted
Oct 24, 2022

2006 – 2022

United States locations

U.S. sites
19
U.S. states
7
U.S. cities
13
Facility City State ZIP Site status
Children's Hospital of Alabama Birmingham Alabama 35233
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233
Banner University Medical Center - Tucson Tucson Arizona 85719
Arkansas Children's Hospital Little Rock Arkansas 72202-3591
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Kaiser Permanente Downey Medical Center Downey California 90242
Children's Hospital Los Angeles Los Angeles California 90027
Mattel Children's Hospital UCLA Los Angeles California 90095
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095
Valley Children's Hospital Madera California 93636
Kaiser Permanente-Oakland Oakland California 94611
Lucile Packard Children's Hospital Stanford University Palo Alto California 94304
UCSF Medical Center-Mount Zion San Francisco California 94115
UCSF Medical Center-Parnassus San Francisco California 94143
UCSF Medical Center-Mission Bay San Francisco California 94158
Children's Hospital Colorado Aurora Colorado 80045
University of Connecticut Farmington Connecticut 06030
Connecticut Children's Medical Center Hartford Connecticut 06106
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00274937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2022 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00274937 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →